Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes and more recently for obesity and other labeled ...

Serious consideration must be given by FDA as to whether the agency has the authority to dispatch the self-affirmed Generally ...

A new vaping industry lawsuit has been filed against the state of North Carolina over its recent law regulating the sale of ...

The US Supreme Court on Monday declined to review the partial reinstatement of a lawsuit from parents alleging baby food ...

The bipartisan FDA Modernization Act 2.0, which became law in 2022, paved the way for the latest step at the FDA. The bill amended the Federal Food, Drug, and Cosmetic Act to remove a requirement ...

WASHINGTON (Reuters) -A Justice Department unit that handles criminal and civil enforcement of U.S. food and drug safety laws ...

The executive order asks for recommendations to promote “a more competitive, efficient, transparent, and resilient ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes and more recently for obesity and other labeled ...

The bipartisan FDA Modernization Act 2.0, which became law in 2022, paved the way for the latest step at the FDA. The bill amended the Federal Food, Drug, and Cosmetic Act to remove a requirement ...